Correlation Between Immune-Related Adverse Events and Efficacy in Non-Small Cell Lung Cancer Treated with Nivolumab

被引：0
|
作者：
Sato, K. [1 ]
Akamatsu, H. [1 ]
Eriko, M. [1 ]
Sakaki, S. [1 ]
Kanai, K. [1 ]
Hayata, A. [1 ]
Tokudome, N. [1 ]
Akamatsu, K. [1 ]
Koh, Y. [1 ]
Ueda, H. [1 ]
Nakanishi, M. [1 ]
Yamamoto, N. [1 ]
机构：
[1] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Non-small-cell lung cancer(NSCLC); Nivolumab; immune-related Adverse Events(irAEs);
D O I：
10.1016/j.jtho.2017.11.094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.07-035
引用
收藏
页码：S2428 / S2429
页数：2
相关论文
共 50 条
  • [1] Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab
    Sato, Koichi
    Akamatsu, Hiroaki
    Murakami, Eriko
    Hayata, Atsushi
    Tokudome, Nahomi
    Akamatsu, Keiichiro
    Koh, Yasuhiro
    Ueda, Hiroki
    Nakanishi, Masanori
    Yamamoto, Nobuyuki
    ANNALS OF ONCOLOGY, 2017, 28 : 86 - 86
  • [2] Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab
    Sato, Koichi
    Akamatsu, Hiroaki
    Murakami, Eriko
    Sasaki, Seigo
    Kanai, Kuninobu
    Hayata, Atsushi
    Tokudome, Nahomi
    Akamatsu, Keiichiro
    Koh, Yasuhiro
    Ueda, Hiroki
    Nakanishi, Masanori
    Yamamoto, Nobuyuki
    LUNG CANCER, 2018, 115 : 71 - 74
  • [3] Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small Cell Lung Cancer
    Haratani, Koji
    Hayashi, Hidetoshi
    Chiba, Yasutaka
    Kudo, Keita
    Yonesaka, Kimio
    Kato, Ryoji
    Kaneda, Hiroyasu
    Hasegawa, Yoshikazu
    Tanaka, Kaoru
    Takeda, Masayuki
    Nakagawa, Kazuhiko
    JAMA ONCOLOGY, 2018, 4 (03) : 374 - 378
  • [4] Association between immune-related adverse events and efficacy of nivolumab in advanced non-small cell lung cancer
    Usui, Yuko
    Udagawa, Hibiki
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Niho, Seiji
    Goto, Koichi
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab (vol 115, pg 71, 2018)
    Sato, Koichi
    Akamatsu, Hiroaki
    Murakami, Eriko
    Sasaki, Seigo
    Kanai, Kuninobu
    Hayata, Atsushi
    Tokudome, Nahomi
    Akamatsu, Keiichiro
    Koh, Yasuhiro
    Ueda, Hiroki
    Nakanishi, Masanori
    Yamamoto, Nobuyuki
    LUNG CANCER, 2018, 126 : 230 - 231
  • [6] Impact of Immune-Related Adverse Events on Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
    Ricciuti, B.
    Genova, C.
    De Giglio, A.
    Brambilla, M.
    Bassanelli, M.
    Dal Bello, M. G.
    Baglivo, S.
    Metro, G.
    Grossi, F.
    Chiari, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S390 - S391
  • [7] Correlation Between Immune-Related Adverse Events and Efficacy of Immune-Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    Del Carpio Huerta, L.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Genua Trullos, I.
    Tuneu Valls, L.
    Stantonyonge Sesnic, N.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruellal, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S485 - S486
  • [8] Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab
    Kothari, Shawn
    Bagley, Stephen
    Aggarwal, Charu
    Baum, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1290 - S1290
  • [9] Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer
    Blazek, Jiri
    Hosek, Petr
    Hrabcova, Karolina
    Bratova, Monika
    Kultan, Juraj
    Hrnciarik, Michal
    Cernovska, Marketa
    Zemanova, Petra
    Krejci, Jana
    Koubkova, Leona
    Stastny, Marek
    Svaton, Martin
    IN VIVO, 2023, 37 (05): : 2229 - 2236
  • [10] Association between immune-related dermatologic adverse events and efficacy of pembrolizumab in non-small cell lung cancer patients
    Fukuoka, T.
    Yamamoto, Y.
    Utsunomiya, J.
    Usami, E.
    Kimura, M.
    Yoshimura, T.
    Nakamura, M.
    Toda, Y.
    PHARMAZIE, 2021, 76 (05): : 239 - 242
12345